---
title: "\"Performance\" Cloudbreak's annual loss narrowed to USD 67.66 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281107709.md"
description: "Cloudbreak announced its 2025 annual results, with losses narrowing to USD 67.66 million, compared to a loss of USD 99.13 million in the same period last year; the loss per share is USD 0.1. No dividend is declared"
datetime: "2026-03-31T01:45:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281107709.md)
  - [en](https://longbridge.com/en/news/281107709.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281107709.md)
---

# "Performance" Cloudbreak's annual loss narrowed to USD 67.66 million

Cloudbreak (02592.HK) announced its 2025 annual results, with losses narrowing to USD 67.66 million, compared to a loss of USD 99.13 million in the same period last year; loss per share is USD 0.1. No dividend is declared

### Related Stocks

- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [02592.HK](https://longbridge.com/en/quote/02592.HK.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)

## Related News & Research

- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md)
- [Ab&B Bio-Tech Starts Early-Stage Trials for High-Yield RSV Vaccine as Trading Remains Suspended](https://longbridge.com/en/news/286268861.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)
- [Wuxi AppTec to Raise Around $1 Billion Through Zero Coupon Convertible Bonds](https://longbridge.com/en/news/286487023.md)